Pacific Biosciences of California, Inc. (PACB) financial statements and ratios from SEC XBRL: revenue $160.00M (TTM), net margin -341.5%, revenue growth -1.9% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $160.00M |
| Net Margin | -341.5% |
| Revenue Growth (YoY) | -1.9% |
| EPS Growth (YoY) | 0.0% |
| FCF Growth (YoY) | 24.1% |
| Price / Sales | 2.39 |
| FCF Yield | -32.4% |
| Altman Z-Score | -6.19 (distress) |
| Sector P/E (Technology) | 33.9 |
PACB overview · PACB earnings · PACB KPIs · PACB investor relations · PACB ownership · PACB peers · PACB filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.